Nephrocare Health Services Limited has informed the Exchange regarding Appointment of M/s. BDO India LLP as Internal Auditor of the company.
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services held its Board Meeting on May 19, 2026, approving multiple items. The company reported standalone FY26 revenue of Rs. 6,297.43 million (up from Rs. 5,435.97 million in FY25), but recorded a loss before tax of Rs. 37.69 million compared to a profit of Rs. 453.60 million in FY25. The loss was partly due to a non-cash, non-recurring interest expense of Rs. 371.89 million on financial liabilities measured at FVTPL. The company also approved investment of up to Rs. 10 crore in its Nepal subsidiary, and provision of collateral/security support aggregating up to Rs. 70 crore each for its Singapore and Saudi Arabia subsidiaries. Additionally, M/s. BDO India LLP was re-appointed as Internal Auditor for FY 2026-27. The company completed its IPO in December 2025, raising funds through issue of 18.9 million shares at Rs. 460 per share.
The FY26 loss may concern shareholders given the strong FY25 profit, though the IPO proceeds and expansion plans (Rs. 10 crore for Nepal operations, Rs. 140 crore collateral support for overseas subsidiaries) indicate strategic growth initiatives. The re-appointment of BDO India LLP as internal auditor is routine governance and has no negative implications.